Executive Director, Winship Cancer Institute@Emory University, Professor and Chairman, Emory Radiation Oncology
Radiation Oncology
Dr. Walter J. Curran, MD
|
|
Give Review
Walter Curran practices Radiation Oncology. He graduated from Medical College of Georgia School of Medicine. Doctor Walter J. Curran, MD is a published doctor and has 97 publications published. The lastest was: 'Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical Trials.' Walter Curran is registered with Medicare.
Publications
- Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases.
- Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical Trials.
- Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study.
- High nuclear hypoxia-inducible factor 1 alpha expression is a predictor of distant recurrence in patients with resected pancreatic adenocarcinoma.
- Quantitative Ultrasonic Nakagami Imaging of Neck Fibrosis After Head and Neck Radiation Therapy.
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage I...
- Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525.
- Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab.
- Automated Segmentation of the Parotid Gland Based on Atlas Registration and Machine Learning: A Longitudinal MRI Study in Head-and-Neck Radiation Therapy.
- Post-Operative Radiotherapy (PORT) is Associated with Better Survival in Non-Small Cell Lung Cancer with Involved N2 Lymph Nodes: Results of an Analysis of the Nationa...
- Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapy.
- Combining Targeted Agents With Modern Radiotherapy in Soft Tissue Sarcomas.
- Clinical trials in thoracic radiation oncology: as easy as 1, 2, 3.
- A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.
- Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cance...
- Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery ...
- Exercise-induced lung cancer regression: Mechanistic findings from a mouse model.
- EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: A secondary analysis of RTOG 0324.
- Patterns of presentation and failure in patients with gliomatosis cerebri treated with partial-brain radiation therapy.
- Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis.
- Outcomes and patterns of failure for grade 2 meningioma treated with reduced-margin intensity modulated radiation therapy.
- A randomized trial of bevacizumab for newly diagnosed glioblastoma.
- Ultrasonic Nakagami-parameter characterization of parotid-gland injury following head-and-neck radiotherapy: A feasibility study of late toxicity.
- Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductase.
- Automated skin segmentation in ultrasonic evaluation of skin toxicity in breast cancer radiotherapy.
- Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial.
- Consolidation chemotherapy after chemoradiation?: not the right answer to not the right question?
- Novel Small-Molecule Inhibitors of Bcl-XL to Treat Lung Cancer.
- Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer.
- Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.
- Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer.
- Four-dimensional (4D) Motion Detection to Correct Respiratory Effects in Treatment Response Assessment Using Molecular Imaging Biomarkers.
- RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients.
- Future vision for the quality assurance of oncology clinical trials.
- Clinical outcomes for a novel 6 degrees of freedom image guided localization method for frameless radiosurgery for intracranial brain metastases.
- A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806).
- Voxel clustering for quantifying PET-based treatment response assessment.
- Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study.
- c-Myc suppression of DNA double-strand break repair.
- A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer.
- Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: Analysis of 655 patients and revie...
- Phase I Trial Using the Proteasome Inhibitor Bortezomib and Concurrent Chemoradiotherapy for Head-and-Neck Malignancies.
- RNAi-mediated targeting of non-coding and coding sequences in DNA repair gene messages efficiently radiosensitizes human tumor cells.
- Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma: A Radiation Therapy Oncology Group Analysis.
- NNK promotes migration and invasion of lung cancer cells through activation of c-Src/ PKC?/ FAK loop.
- Rapamycin Induces Bad Phosphorylation in Association with Its Resistance to Human Lung Cancer Cells.
- Radiosensitizing Effects of Ectopic miR-101 on Non-Small-Cell Lung Cancer Cells Depend on the Endogenous miR-101 Level.
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410.
- In response to dr. Rogers and colleagues.
- Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non-Small-Cell Lung Cancer: Analysis of the Radiation...
- Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy.
- Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small-Cell Lung Cancer: RTOG 0324.
- A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system maligna...
- Validation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51.
- Longitudinal oncology registry of head and neck carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States.
- Reliability of quantitative ultrasonic assessment of normal-tissue toxicity in breast cancer radiotherapy.
- A noninvasive integrative method for analyzing radiation-induced lung injury.
- Age as an independent prognostic factor in patients with glioblastoma: a radiation therapy oncology group and American College of Surgeons National Cancer Data Base co...
- Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
- Higher Biologically Effective Dose of Radiotherapy is Associated with Improved Outcomes for Locally Advanced Non-Small Cell Lung Carcinoma Treated with Chemoradiation:...
- Consideration of Dose Limits for Organs at Risk of Thoracic Radiotherapy: Atlas for Lung, Proximal Bronchial Tree, Esophagus, Spinal Cord, Ribs, and Brachial Plexus.
- Validation and Simplification of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification for Glioblastoma.
- Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.
- Combined modality therapy for stage III non-small-cell lung cancer.
- Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.
- Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irrad...
- Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
- The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials.
- Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects.
- Mono- or double-site phosphorylation distinctly regulates the proapoptotic function of Bax.
- Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation.
- Dosimetric performance of the new high-definition multileaf collimator for intracranial stereotactic radiosurgery.
- Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTO...
- Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.
- For whom the Bell's Palsy tolls?
- Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies.
- Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohorts.
- Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.
- Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database.
- Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of nonacoustic cranial nerve schwannomas.
- Celebrating 40 years of clinical inquiry: The RTOG'S ruby anniversary.
- Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thal...
- A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
- Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization.
- Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
- The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression.
- Imaging response in malignant glioma, RTOG 90-06.
- A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer.
- Therapy for stage III non-small-cell lung cancer: Bob Beamon or Chemo-Beamo?
- Impact of Her-2 Neu overexpression on outcome of elderly women treated with wide local excision and breast irradiation for early stage breast cancer: an exploratory an...
- Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Onco...
- Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modalit...
- Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-...
- Glycerol rhizotomy versus gamma knife radiosurgery for the treatment of trigeminal neuralgia: an analysis of patients treated at one institution.
- MRI changes due to early-delayed conformal radiotherapy and postsurgical effects in patients with brain tumors.
Schools
Medical College Of Georgia School Of Medicine
Presby University Penn Med College
Hospital Of The University Of Pennsylvania
Doctors Specialties
- Radiation Oncology
- Radiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Choice HMO
- Blue Choice Option POS
- Blue Open Access POS
- Great West Healthcare-Cigna PPO
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- GEHA
- Choice Care PPO
- Kaiser Permanente
- MedHealthInsurance
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Pennsylvania Health System -
University of Pennsylvania -
Medical College of Georgia School of Medicine
Hospital
-
Emory University Hospital -
Emory University Hospital Midtown -
Grady Memorial Hospital
Drug Facts
| NPI NUMBER | 1326060773 | |
| NPPES Provider LastName | CURRAN | |
| NPPES Provider FirstName | WALTER | |
| NPPES Provider ZIPCode | 303221013 | |
| NPPES Provider State | GA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 15.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326060773 |
| Last Name Of The Provider | CURRAN |
| First Name Of The Provider | WALTER |
| View All |
Similar Doctors
|
|
Dr. Mylin A. Torres, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam W. Nowlan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda K. Wobeck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott Edelman, MD |
|
|
Dr. Kelly T. Drake, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Henry D. Cline, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jerome Landry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey B. Lichtman, MD |
|
|
Dr. William A. Davis III, MD |
|
|
Dr. Jaymin P. Jhaveri, MD |
|
|
Dr. Naresh K. Jegadeesh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John L. Mikell, MD |